2022 / 01

Next Paper
DOI: 10.47183/mes.2022.005

ORIGINAL RESEARCH

Hepatitis B, C and TTV virus infection in highly trained athletes

Melnikova LI1, Kozhanova TV2, Ilchenko LYu2,3, Morozov IA2, Soboleva NV2, Nguyen Thi-Hanh3, Kruglova IV4, Gordeychuk IV2
About authors

1 Clinical Hospital № 85 of Federal Medical-Biological Agency, Moscow, Russia

2 Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products, Moscow, Russia

3 Pirogov Russian National Research Medical University, Moscow, Russia

4 Federal Research and Clinical Center for Sports Medicine and Rehabilitation of the Federal Medical Biological Agency, Moscow, Russia

Correspondence should be addressed: Lubov I. Melnikova
Kashirskoe shosse, 13G, Moscow, 115230, Russia; ur.liam@561lem

About paper

Author contribution: Melnikova LI, Kruglova IV — collection of material, data analysis; Kozhanova TV — identification of markers of hepatitis virus infection, manuscript writing; Ilchenko LYu — research design development, data analysis; Morozov IA — research design, manuscript editing; Soboleva NV — identification of the hepatitis virus infection markers, statistical data processing; Nguyen Thi-Hanh — literature analysis; Gordeychuk IV — manuscript editing, approval of the final version of the article.

Compliance with ethical standards: the study was approved by the Ethics Commitee of the Clinical Hospital No. 85 of FMBA of Russia (protocol № 157 dated September 19, 2018). All subjects submitted the informed consent to blood sampling, identification of the hepatitis virus infection markers, and publication of results.

Received: 2022-02-16 Accepted: 2022-03-05 Published online: 2022-03-22
|
  1. Samojlov AS, Razinkin SM, Petrova VV. Provedenie jetapnogo medicinskogo obsledovanija sportsmenov ciklicheskih vidov sporta na baze specializirovannogo centra sportivnoj mediciny. M.: FMBA Rossii, 2018; 65 s. Russian.
  2. Meeusen R, Duclos M, Foster C, et al. Prevention, Diagnosis, and Treatment of the Overtraining Syndrome: Joint Consensus Statement of the European College of Sport Science and the American College of Sports Medicine. Medicine and Science in Sports and Exercised. 2013; 45 (1): 186–205. DOI: 10.1249/ MSS.0b013e318279a10a.
  3. Lanini S, Ustianowski A, Pisapia R, et al. Viral Hepatitis: Etiology, Epidemiology, Transmission, Diagnostics, Treatment, and Prevention. Infect Dis Clin North Am. 2019; 33 (4): 1045–62. DOI: 10.1016/j.idc.2019.08.004.
  4. Ninomiya M, Nishizawa T, Takahashi M, et al. Identification and genomic characterization of a novel human torque teno virus of 3.2 kb. J Gen Virol. 2007; 88 (7): 1939–44. DOI: 10.1099/vir.0.82895-0.
  5. O sostojanii sanitarno-jepidemiologicheskogo blagopoluchija naselenija v Rossijskoj Federacii v 2020 godu: Federal'naja sluzhba po nadzoru v sfere zashhity prav potrebitelej i blagopoluchija cheloveka, 2021; 256 s. Russian.
  6. Harrington DW. Viral hepatitis and exercise. Med Sci Sports Exerc. 2000; 32: 422–30.
  7. Melnikova LI, Ilchenko LYu, Zubkov YuP, Kruglova IV, Samojlov AS., Gordejchuk I. V. i dr. Sovremennaja laboratornaja diagnostika, protivovirusnaja terapija i profilaktika hronicheskih gepatitov V, S, D u sportsmenov. Moskva, 2013; 70 s. Russian.
  8. Bruckner P, Khan K: Common sports-related infections. In Clinical Sports Medicine, edn 2. Edited by Bruckner P, Khan K. Sydney: The McGraw-Hill Companies. 2000: 779–86.
  9. Haley RW, Fischer RP: Commercial tattooing as a potentially important source of hepatitis C infection: clinical epidemiology of 626 consecutive patients unaware of their hepatitis C serological status. Medicine. 2001; 80: 134–51.
  10. Tobe K, Matsuura K, Ogura T, et al.: Horizontal transmission of hepatitis B among players of an American football team. Arch Intern Med. 2000; 160: 2541–5.
  11. Morozov IA, Il'chenko LJu, Fedorov IG. i dr. Skrytyj gepatit V: klinicheskoe znachenie i problemy diagnostiki. Arhiv" vnutrennej mediciny. 2012; 4 (6): 39–45. Russian.
  12. HEPAHEALTH. Project Report. Risk Factors and the Burden of Liver Disease in Europe and Selected Central Asian Countries. [Electronic resource]. Available from: www.easl.eu (date of the application: 25.11.2021).
  13. Nishizawa T, Okamoto H, Konishi K, Yoshizawa H, Miyakawa Y, Mayumi M. A Novel DNA Virus (TTV) Associated With Elevated Transaminase Levels in Posttransfusion Hepatitis of Unknown Etiology. Biochem Biophys Res Commun. 1997; 241 (1): 92–7. DOI: 10.1006/bbrc.1997.7765.
  14. Virus Taxonomy: 2018b Release. Available from: https://talk.ictvonline.org/taxonomy (date of the application: 25.11.2021).
  15. Al-Qahtani АА, Alabsi ES, Abu Odeh R, et al. Prevalence of anelloviruses (TTV, TTMDV, and TTMV) in healthy blood donors and in patients infected with HBV or HCV in Qatar. J Virology. 2016; 13 (1): 208–13. DOI: 10.1186/s12985-016-0664-6.
  16. Itoh Y, Takahashi M, Fukuda M, et al. Visualization of TT virus particles recovered from the sera and feces of infected humans. Biochem Biophys Res Commun. 2000; 279 (2): 718–24. DOI: 10.1006/bbrc.2000.4013.
  17. Morozov IA, Zverkova EA, Kyuregyan KK, i dr. Virusy roda Anelloviridae pri hronicheskoj patologii pecheni. Jeksperimental'naja klinicheskaja gastrojenterologija. 2015; 7 (119): 4–11. Russian.
  18. Ilchenko LYu, Morozov IA, Kozhanova TV, i dr. Vyjavljaemost' markerov inficirovanija virusami gepatitov u vysokokvalificirovannyh sportsmenov. Arhiv" vnutrennej mediciny. 2020; 4: 305–13. DOI: 10.20514/2226-6704-2020-10-4-305-313. Russian.